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In another 20 neonates, the efficiency of exchange transfusion in removing bilirubin was compared. The efficiency was decreased by early albumin priming and enhanced by enriching the donor's blood with albumin.
It is concluded that albumin offers immediate and short-term protection against bilirubin toxicity, and albumin-priming should be useful in situations where the babies are admitted with high bilirubin levels and blood is not immediately available for exchange transfusion. Because of its effect on the plasma volume, albumin is not recommended for babies who are already hypervolaemic. If albumin is used to increase the efficiency of exchange transfusion, it should be given together with donor's blood or shortly before the procedure.
Bilirubin exists in human plasma largely bound to albumin (Ostrow and Schmid, 1963) . Only a small amount is present in the free or diffusible form (Odell, 1959a; Bumstine and Schmid, 1962) . It is the latter fraction which determines its toxicity. Many factors, such as pH, ionic concentration, and the presence of organic anions that compete with bilirubin for the binding site, can influence the dissociation of the albumin-bilirubin complex (Harris, Lucey, and MacLean, 1958; Odell, 1959b Odell, , 1970 . However, given the same conditions, an increased amount of albumin is protective against bilirubin toxicity by providing more binding sites, thereby reducing the level of free bilirubin. Furthermore, though crystalline albumin is capable of binding bilirubin up to molar ratio of 1 : 2 at pH 7-4 the first molecule of bilirubin is more tightly bound to albumin than the second molecule Received 6 October 1971. (Odell, 1959a) and the binding capacity of plasma albumin is already much reduced because of the presence of other organic anions.
Albumin has been used to raise the serum albumin level in premature babies (Odell, 1959a) , and in association with exchange transfusion to increase bilirubin removal (Kitchen, Krieger, and Smith, 1960; Odell, Cohen, and Gordes, 1962; Comley and Wood, 1968) . In situations where the neonate is admitted with high serum bilirubin level and when blood is not readily available for exchange transfusion, albumin may offer protection against kernicterus, and may even extract bilirubin which has already diffused into the tissues (Diamond and Schmid, 1966). Odell (1959a) found that the administration of albumin to babies with hyperbilirubinaemia caused a rise in the level of serum bilirubin, and therefore reasoned that the efficiency of bilirubin removal would be increased thereby. Other workers (Lucey, 1966; Diamond, 1969) 250 expressed caution that such rise in serum bilirubin level would remove one of the main danger signals and indications for exchange transfusion. Ruys and van Gelderen (1962) did not find such a rise after priming 3 neonates with albumin. Our previous experience of albumin priming in 10 neonates concurred with the findings of the latter workers.
In Hong Kong, many newborn babies are admitted into hospital with high levels of serum bilirubin. Rhesus incompatability is rare (Grimmo and Lee, 1961) and many of these babies do not show evidence of active haemolysis. The serum bilirubin does not rise very rapidly. The effectiveness of phenobarbitone in lowering the serum bilirubin level (Yeung and Field, 1969) and in facilitating the hepatic handling of bromsulphalein in these infants (Yeung and Yu, 1971) suggests that the hyperbilirubinaemia may be the result of reduced glucuronyl transferase activity during the early neonatal period. These patients, therefore, provide an ideal situation for studying the effects of albumin administration on the distribution of bilirubin in the body.
The present study was undertaken to delineate the changes occurring during the first few hours after albumin administration and the effect of the latter on exchange transfusion so that more rational use may be made of albumin in the management of neonatal hyperbilirubinaemia.
Material and Methods
Twenty-seven term infants between 3 and 14 days of age, with serum bilirubin levels between 13-5 and 39*5 mg/100 ml and no known haemolytic disease, were selected for this study. They were all screened for rhesus and ABO group incompatibilities, red blood cell G6PD and pyruvate kinase deficiencies, direct Coombs test, Hb, packed cell volume, and reticulocyte count.
The study was divided into two parts. The first part was designed to study the changes occurring during the first few hours after albumin priming: 7 babies were included in this study. Each was given salt-poor human albumin (Cutter) as a 10% solution via an umbilical venous catheter at a dose of 1-75 g/kg body weight over a period of approximately 2 minutes. Blood samples were taken immediately before the infusion, 5 minutes after the infusion, and thereafter at halfhourly or hourly intervals for as long as the circumstances would permit. The blood samples were divided into 2 portions: one in EDTA bottles for estimations of Hb and packed cell volume, and the other in plain bottles with light-proof wrappings to extract serum for total bilirubin, serum albumin and 2(4'-hydroxyazobenzene) benzoic acid (HBABA) binding capacity.
The second part of the study was to determine the effect of albumin administration on subsequent exchange transfusion: 20 babies were included in this study; 7 were given albumin as above approximately 3 hours before the exchange transfusion (Group A); 7 received a simple exchange transfusion without the use of albumin (Group B). Six received no albumin before the exchange transfusion, but had 1*5 g albumin added to every 100 ml of the donor's blood. The albuminenriched donor's blood was then used for exchange transfusion (Group C). No attempt was made to render the 3 groups comparable as regards birthweight, gestational age, etc. However, they were all term infants with birthweight above 2500 g. The only criterion for inclusion in the study was that they did not have a haemolytic disease. A rigid two-volume exchange transfusion was not employed. For these reasons, the efficiency of bilirubin removal by exchange transfusion is expressed as percentage of the theoretical bilirubin clearance from plasma by serial dilution with donor's blood, assuming that no diffusion is taking place. The method of calculation is given below.
Blood samples were taken from the patients before albumin priming (where applicable), before exchange transfusion, and after exchange transfusion. A sample of blood used for exchange transfusion was also taken at the beginning and at the end of the procedure. Heparin was added to the 'waste' blood to prevent clotting. All the blood samples were analysed for Hb content, packed cell volume, total bilirubin, and HBABA binding capacity.
Total bilirubin was determined spectrophotometrically (Chiamori, Henry, and Golub, 1961) . HBABA binding capacity was done according to the method described by Porter and Waters (1966) . Serum albumin was measured by the biuret method after salting out with 280o sodium sulphite. Screening tests for red blood cell glucose-6-phosphate dehydrogenase, and pyruvate kinase deficiencies were carried out using Beutler's fluorescence spot techniques (Beutler, 1966 (Fig. 1) . There was an increase in the total intravascular bilirubin, reaching a peak about half an hour after albumin priming (Fig. 2) . Thereafter, it showed a gradual decline except in two patients who showed a secondary rise. This corresponded with the changes in the plasma volume.
The total intravascular albumin was much increased after albumin priming (Fig. 3) . It then fell gradually suggesting diffusion out of the intravascular compartment. Towards the end of the observation period, the total intravascular albumin was still raised but there was a tendency to level off, indicating that a new equilibrium had been established.
The HBABA-binding capacity, expressed either as per 100 ml plasma or as total intravascular HBABA-binding capacity, was also raised after albumin priming (Fig. 4) . Both tended to level off at a raised level after the first hour. Thus, the reserve binding capacity of the patient's plasma was shown to be increased throughout the period of study. When the efficiency of exchange transfusion in the 3 groups of babies was compared in the second part of the study, it was lowest in those babies who had been primed with albumin 3 hours before exchange transfusion, and was highest in those who received albumin-enriched donor's blood (Fig. 5) . The details are shown in the At the end of the observation period, there was a net gain of bilirubin within the intravascular compartment, together with an increased HBABAbinding capacity, expressed either in terms of total intravascular albumin or in terms of per unit volume of plasma. The shift of bilirubin into the intravascular compartment resulted in a corresponding reduction of extravascular bilirubin. With increased reserve binding capacity of the intravascular albumin, the toxic diffusible fraction of bilirubin can be expected to be correspondingly reduced.
In these 7 patients, the serum bilirubin level did not vary to any great extent after albumin priming. (Odell, 1970 mainly for its initial protective function, then the sooner the exchange transfusion can be carried out after the priming, the greater will be its effect on the efficiency of bilirubin removal.
